204 related articles for article (PubMed ID: 14694955)
41. Diabetes does not affect ventricular repolarization and sudden cardiac death risk in patients with dilated cardiomyopathy.
Vrtovec B; Fister M; Poglajen G; Starc V; Haddad F
Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S146-50. PubMed ID: 19250080
[TBL] [Abstract][Full Text] [Related]
42. Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
Maron BJ; Maron MS; Lesser JR; Hauser RG; Haas TS; Harrigan CJ; Appelbaum E; Main ML; Roberts WC
Am J Cardiol; 2008 Feb; 101(4):544-7. PubMed ID: 18312775
[TBL] [Abstract][Full Text] [Related]
43. Sudden cardiac death in pediatrics.
Bar-Cohen Y; Silka MJ
Curr Opin Pediatr; 2008 Oct; 20(5):517-21. PubMed ID: 18781113
[TBL] [Abstract][Full Text] [Related]
44. Recurrent thrombo-embolism in a child with a congenital disorder of glycosylation (CDG) type Ib and treatment with mannose.
Tamminga RY; Lefeber DJ; Kamps WA; van Spronsen FJ
Pediatr Hematol Oncol; 2008 Dec; 25(8):762-8. PubMed ID: 19065443
[TBL] [Abstract][Full Text] [Related]
45. Cardiomyopathy, an uncommon phenotype of congenital disorders of glycosylation: Recommendations for baseline screening and follow-up evaluation.
Zemet R; Hope KD; Edmondson AC; Shah R; Patino M; Yesso AM; Berger JH; Sarafoglou K; Larson A; Lam C; Morava E; Scaglia F
Mol Genet Metab; 2024 Jun; 142(4):108513. PubMed ID: 38917675
[TBL] [Abstract][Full Text] [Related]
46. Hypertrophic cardiomyopathy: risk factors for life and living benefits insurance.
Pokorski RJ
J Insur Med; 2002; 34(1):43-60. PubMed ID: 15303593
[TBL] [Abstract][Full Text] [Related]
47. Defective protein glycosylation in patients with cutis laxa syndrome.
Morava E; Wopereis S; Coucke P; Gillessen-Kaesbach G; Voit T; Smeitink J; Wevers R; Grünewald S
Eur J Hum Genet; 2005 Apr; 13(4):414-21. PubMed ID: 15657616
[TBL] [Abstract][Full Text] [Related]
48. [The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste].
Di Lenarda A; Pinamonti B; Mestroni L; Salvi A; Sabbadini G; Gregori D; Perkan A; Zecchin M; Carniel E; Bussani R; Silvestri F; Morgera T; Camerini F; Sinagra G;
Ital Heart J Suppl; 2004 Apr; 5(4):253-66. PubMed ID: 15346692
[TBL] [Abstract][Full Text] [Related]
49. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
[TBL] [Abstract][Full Text] [Related]
50. Familial occurrence in cardiovascular diseases. Familial cardiovascular diseases (1).
Sangiorgi M; Fragola PV; Capria A
Ann Ital Med Int; 1989; 4(1):32-9. PubMed ID: 2702015
[TBL] [Abstract][Full Text] [Related]
51. From discrete dilated cardiomyopathy to successful cardiac transplantation in congenital disorders of glycosylation due to dolichol kinase deficiency (DK1-CDG).
Kapusta L; Zucker N; Frenckel G; Medalion B; Ben Gal T; Birk E; Mandel H; Nasser N; Morgenstern S; Zuckermann A; Lefeber DJ; de Brouwer A; Wevers RA; Lorber A; Morava E
Heart Fail Rev; 2013 Mar; 18(2):187-96. PubMed ID: 22327749
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to pre-participation screening.
Basavarajaiah S; Wilson M; Whyte G; Shah A; McKenna W; Sharma S
J Am Coll Cardiol; 2008 Mar; 51(10):1033-9. PubMed ID: 18325444
[TBL] [Abstract][Full Text] [Related]
53. Role of invasive electrophysiologic testing in risk stratification for sudden cardiac death.
Saeed M; Homoud MK; Wang PJ; Estes NA; Link MS
J Invasive Cardiol; 2001 Nov; 13(11):758-62. PubMed ID: 11689722
[No Abstract] [Full Text] [Related]
54. Small coronary artery disease in cardiomyopathy: hypertrophic cardiomyopathy resembling dilated cardiomyopathy.
Fujiwara H; Nishigaki K
Coron Artery Dis; 1995 Mar; 6(3):213-9. PubMed ID: 7788033
[No Abstract] [Full Text] [Related]
55. Prenatal cardiac ultrasound finding in congenital disorder of glycosylation type 1a.
Malhotra A; Pateman A; Chalmers R; Coman D; Menahem S
Fetal Diagn Ther; 2009; 25(1):54-7. PubMed ID: 19176971
[TBL] [Abstract][Full Text] [Related]
56. Female infant with oncocytic cardiomyopathy and microphthalmia with linear skin defects (MLS): a clue to the pathogenesis of oncocytic cardiomyopathy?
Bird LM; Krous HF; Eichenfield LF; Swalwell CI; Jones MC
Am J Med Genet; 1994 Nov; 53(2):141-8. PubMed ID: 7856638
[TBL] [Abstract][Full Text] [Related]
57. What's new in congenital disorders of glycosylation?
Jaeken J; Carchon H
Eur J Paediatr Neurol; 2000; 4(4):163-7. PubMed ID: 11008258
[No Abstract] [Full Text] [Related]
58. A fetal dilated and hypertrophic cardiomyopathy associated with maternal gestational diabetes--a case report.
Dawid G; Węgrzynowski J; Kwiatek M; Biczysko-Mokosa A; Petriczko E; Horodnicka-Józwa A
Pediatr Endocrinol Diabetes Metab; 2010; 16(2):123-5. PubMed ID: 20813091
[TBL] [Abstract][Full Text] [Related]
59. Cardiovascular involvement in metabolic diseases.
Gilbert-Barness E
Pediatr Pathol Mol Med; 2002; 21(2):93-136. PubMed ID: 11942539
[TBL] [Abstract][Full Text] [Related]
60. Sudden cardiac death in infancy due to histiocytoid cardiomyopathy.
Grech V; Ellul B; Montalto SA
Cardiol Young; 2000 Jan; 10(1):49-51. PubMed ID: 10695541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
